GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Scot Niglio discussing two abstracts: “Safety and efficacy of neoadjuvant immunotherapy with ...

The Federal Public Service Commission (FPSC) has officially confirmed that the Central Superior Services (CSS) 2025 examination will proceed as planned, beginning tomorrow (Saturday, 5, 2025).

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

Discover Unique Nail Art Inspiration!!

According to police sources, coordination between the district administration, security agencies, and other departments had ...

The Islamabad High Court (IHC) has rejected a petition that sought to delay the upcoming Central Superior Services (CSS) 2025 ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.